X4 Pharmaceuticals (XFOR) Earnings Analysis
X4 Pharmaceuticals (XFOR) next reports earnings on 2026-08-06, consensus EPS -0.19 USD. Last quarter (2026-03-17) it beat with EPS -0.22 USD vs -0.36 USD est (+38.9%). It has beaten estimates in 3/3 recent quarters (100%). Trailing P/E -0.81.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does XFOR next report earnings?
| Next earnings date | 2026-08-06 |
|---|---|
| Consensus EPS estimate | -0.19 USD |
| Revenue estimate | 0.00B |
XFOR earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-17 | -0.22 USD | -0.36 USD | +38.9% | Beat |
| 2025-08-08 | -3.47 USD | -4.53 USD | +23.4% | Beat |
| 2025-05-01 | 0.04 USD | -4.13 USD | +101% | Beat |
Beat rate: 3/3 (100%) over reported quarters with consensus data.
XFOR valuation and analyst view
| Trailing P/E | -0.81 |
|---|---|
| Trailing EPS | -0.78964 USD |
| Price / book | 2.77 |
| Dividend yield | 0.00% |
| Market cap | 0.35B |
| Analyst consensus | Buy (12 buy / 1 hold / 0 sell) |
| Avg price target | 11.5 USD |
Related research pages
Frequently asked questions
When is X4 Pharmaceuticals (XFOR)'s next earnings date?
X4 Pharmaceuticals is next scheduled to report on 2026-08-06, with a consensus EPS estimate of -0.19 USD and revenue estimate of 0.00B.
Did XFOR beat earnings last quarter?
In its 2026-03-17 report, XFOR posted EPS of -0.22 USD versus a -0.36 USD estimate — a beat of 38.9%.
What is XFOR's earnings track record?
Over the last 3 reported quarters with consensus data, XFOR beat estimates 3 times (100%).
What is XFOR's current P/E ratio and EPS?
XFOR trades at a trailing P/E of -0.81 on trailing EPS of -0.7896350333671519 USD.
What do analysts rate XFOR?
Analyst consensus is "Buy" across 13 ratings (0 strong buy, 12 buy, 1 hold, 0 sell, 0 strong sell). Average 12-month price target: 11.5 USD.